News & media
Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.
-
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
-
Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
-
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
-
Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th
-
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
-
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Total number of shares and voting rights in Zealand Pharma on August 30, 2024
-
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
-
Zealand Pharma major shareholder announcement: Bank of America Corporation
-
Zealand Pharma Announces Financial Results for the First Half of 2024
-
Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
Corporate management
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer
-
David Kendall - Executive Vice President, Research & Development and Chief Medical Officer
-
Henriette Wennicke - Executive Vice President and Chief Financial Officer
-
Ivan Møller - Executive Vice President and Chief Operating Officer
-
Ravinder Chahil - Executive Vice President and General Counsel
Research and development
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
Logos and icons
-
)
Zealand Pharma Logo (RGB)
Stay up-to-date with the latest news from Zealand
Sign-up to receive press releases and company announcements directly to your inbox
Investor and Media contacts
